Biotech Trends Update — IP Constituencies: Innovator-Generic Mixing Continues...
As traditional pharma companies continue to diversify their revenue sources in the face of their pending patent cliffs, we have followed their entry into and expansion of their generics business lines....
View ArticleMonday Biotech Deal Review: April 16 2012
Welcome to your Monday Biotech Deal Review for April 16, 2012. Highlights include deals by Bioniche, Valeant and Bunge and $5 million of equity financings. Read on to learn more. Investments Pyng...
View ArticleMonday Deal Review: December 17, 2012
Welcome to your Monday Biotech Deal Review for December 17, 2012. This week saw the completion of a number of previously announced acquisitions, as well as the announcement of new ones. The latter...
View Article
More Pages to Explore .....